A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Sputum, MTB Complex, Rifampin Resistance, PCR
MessageImportant Note
Specimens should be transported as soon as possible and must arrive within 24hrs of collection.
Test Code
Alias/See Also
Includes
Preferred Specimen
Specimen Type: Sputum
Source: Expectorated, induced
Collection Container: Sterile container
Specimen Volume: 2 mL
Instructions
- Sputum previously processed in external laboratories is unacceptable.
- AFB culture is also required when this test is ordered. Sufficient volume must be received to perform both culture and MTB Complex PCR. If insufficient volume is received the MTB Complex PCR will be cancelled.
Transport Container
Specimen Stability
Room temperature: Unacceptable
Refrigerated: 24 hours
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Insufficient specimen volume received for both AFB culture and MTB Complex PCR
Methodology
Real-Time Polymerase Chain Reaction (RT-PCR)
Setup Schedule
Limitations
This test uses qualitative real-time polymerase chain reaction (PCR) for the detection of Mycobacterium tuberculosis complex DNA and rifampin-resistance associated mutations of the rpoB gene. The Xpert MTB/RIF assay is not indicated for use with sputum samples from patients being treated with antituberculosis drugs, either to determine bacteriologic cure or to monitor response to therapy. A positive test does not necessarily indicate the presence of viable organisms. A negative test does not exclude the possibility of isolating Mycobacterium tuberculosis (MTB) complex from the sample. Mycobacteria cultures are required to detect the presence of MTB complex that is below the limit of detection of this assay and also to detect mycobacteria other than tuberculosis complex. Due to the low prevalence of rifampin resistant TB in the United States, specimens with rifampin resistance detected will be sent for confirmatory testing.
Reference Range
Performing Laboratory
Inova Laboratories
2832 Juniper Street
Fairfax, VA 22031
Last Updated: November 28, 2023
Last Review: N. Wolford, May 10, 2023